Bela S. Denes, MD is currently Vice President of Medical Affairs at Blue Earth Diagnostics with responsibilities as outlined below. Previously he was with Genomic Health for 5+ years as Sr. Director of Medical Affairs for Urology. In this role, he was responsible for studies to further define the role of the Oncotype DX® Genomic Prostate Score (GPS) assay in management of men with prostate cancer and took the lead role in launching the Oncotype DX AR-V7 Nucleus Detect test.
Since joining industry in 2003, he has held leadership roles at Eli Lilly, Pfizer, Spectrum and Abbott. Trained and educated at Washington University in St. Louis, he has over 25 years of clinical and academic Urology focusing on both benign and malignant Men’s health issues. He has been the clinical lead in development and execution of Phase 1 – 4 clinical protocol/studies across a number of disease states leading to FDA approval of several medicinal products and devices. Additionally, has presented and published numerous articles, abstracts and posters at conferences both in the U. S. and abroad.